Eli Lilly shares popped early Tuesday after the drugmaker reported first-quarter profit that topped estimates amid strong demand for diabetes and weight-loss drugs.
Eli Lilly’s stock jumps as first-quarter profit tops estimates amid strong sales of Mounjaro, Zepbound
